-
Novo Nordisk Foundation and partners launch global antiviral drug research and development program
Time of Update: 2022-04-22
<> /* Style Definitions */ span. prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a. prnews_a { color:blue; } li. prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p. prne
-
Novartis' multiple sclerosis drug Quanxinda (ofatumumab) issued its first prescription in China
Time of Update: 2022-04-22
Studies have shown that compared with the active control group, ofatumumab can significantly reduce the annual recurrence rate and overall disability progression risk, and has a good safety profile, which is considered to be the first choice for the treatment of RMS [1] .
-
Honeycomb cell culture management "tool" MyCanister is easy to handle!
Time of Update: 2022-04-21
MyCanister is a portable honeycomb cell culture box to help you solve the above problems!MyCanister, jointly developed by Japan's TrueSeed Company and Dr.
-
Beihai Kangcheng's new drug CAN108 for the treatment of Alagille syndrome (NDA/ODR) was accepted by the Taiwan Food and Drug Administration
Time of Update: 2022-04-20
Under the terms of the agreement, Beihai Kangcheng has obtained an exclusive license to develop and commercialize three indications in Greater China for Alagille syndrome (ALGS), progressive familial intrahepatic cholestasis (PFIC) and biliary atresia (BA).
-
Liangmianzhen creates a new marketing model to help brands create the future
Time of Update: 2022-04-20
However, Liangmianzhen has always adhered to the original intention of "making the best traditional Chinese medicine toothpaste", focusing on the development of its main business and focusing on By shaping the sales force, combing the product system, innovating the marketing model, increasing the brand promotion, and gradually restoring its own hematopoietic function .
-
Innovent Announces the First Clinical Patient Dosing of Claudin18.2/CD3 Bispecific Antibody Drug IBI389
Time of Update: 2022-04-20
62em; font-family:"Arial"; color:black; margin:0in; } </>SAN FRANCISCO, USA and SUZHOU, China, March 29, 2022 /PRNewswire/ -- Innovent Biopharmaceutical Group (SEHK: 01801), a research and development, A biopharmaceutical company with innovative drugs for major diseases such as autoimmunity, today announced its self-developed recombinant bispecific antibodies targeting claudin 18.
-
3SBio Announces 2021 Annual Report: Net Profit attributable to Parent Nearly Doubled, Accelerated Development of Diversified Businesses
Time of Update: 2022-04-20
3SBio’s pipelines under development as of 2021 The progress of key projects in the submission of new drug applications and Phase III clinical trials include: The anti-TNF-α pre-filled Yisaipu water injection (301S) has resubmitted the NDA production approval to the State Food and Drug Administration in July 2021, and has been accepted .
-
New Arrivals | Thermo Fisher Announces New Arcturus Cellect Laser Capture Microdissection (LCM) System
Time of Update: 2022-04-20
Are you having trouble enriching your samples? Thermo Fisher has released the new Arcturus Cellect Laser Capture Microdissection (LCM) system to help you efficiently enrich cells and never worry about
-
Positive top-line results from Pfizer's one-year Phase 3 trial of Etrasimod in patients with ulcerative colitis show Best-in-Class potential
Time of Update: 2022-04-19
prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.
Genting Xinyao is conducting a Phase 3 clinical study of etrasimod in Asia for the treatment of moderate to severe ulcerative colitis, with enrollment expected to be completed in 2023 .
-
RNAimmune closes $27M Series A to develop mRNA therapeutics and vaccines
Time of Update: 2022-04-19
, March 30, 2022 /PRNewswire/ -- RNAimmune is a biopharmaceutical company focused on the discovery and development of mRNA-based therapeutics and vaccines .
The company intends to use the funding to further advance its mRNA vaccine and drug development for infectious diseases, cancer and rare diseases .
-
Moderna develops mRNA vaccine for common human cold (coronavirus)
Time of Update: 2022-04-19
The effects of these 4 coronaviruses on humans are not unpredictable and destructive, usually only causing common colds and upper respiratory tract infections .
These four viruses are responsible for 10%-30% of upper respiratory tract infections globally and are the second most common cause of colds after rhinoviruses .
-
Tengsheng Biopharma and Sinopharm Holding reached a strategic cooperation to jointly promote the commercialization of long-acting COVID-19 neutralizing antibodies in China
Time of Update: 2022-04-19
(hereinafter referred to as "Sinopharm Holding") reached a strategic cooperation, and the two parties will work together to promote the company's long-acting new crown monoclonal neutralizing antibody Ambavirumab / romisevirumab combination The commercialization process of the therapy in China, including drug storage, channel distribution, regional access, and other innovative business cooperation, will jointly contribute to the prevention and control of the epidemic in China .
-
Abcam wins six 2022 CiteAb awards
Time of Update: 2022-04-19
Professor Giovanna Roncador , Head of the Monoclonal Antibody Unit / Biotechnology Program at the Spanish National Cancer Institute ( CNIO ), Founder and Chairman of EuroMabNet , and winner of the 2022 CiteAb 'Outstanding Personal Impact' Award , said : " As a cancer scientist and Antibody engineer , I am a firm believer that advancing science and improving reagent quality go hand in hand .
-
Good news!
Time of Update: 2022-04-19
62em; font-family:"Arial"; color:black; margin:0in; } </>BEIJING, March 30, 2022 /PRNewswire/ -- On March 15, 2022, the national key research and development program subject " Development of International Standards for Clinical Pharmacy Services and Dispensing Education in Traditional Chinese Medicine " three international organization standard expert seminars were held in Beijing and Likang Yuan Medical Technology Co.
-
Yuyue Medical's breathing and oxygen-generating products quickly arrived in many makeshift hospitals
Time of Update: 2022-04-18
prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.
Yuyue Breathing Oxygen Products will arrive in Fangcang shelter hospitals within 24 hours Relevant personnel of Yuyue Medical said: "We placed the order on the same day after receiving the demand from the makeshift hospital .
-
Bekang Medical releases 2021 financial report
Time of Update: 2022-04-18
Innovation and R&D drive accelerated upgradesUnder the circumstance that the sales of core products are so bright, Beikang Medical continues to increase investment in research and development to further expand the company's product pipeline in the field of assisted reproduction .
-
Hengrui Medicine's latest research results of camrelizumab appear again at the European Lung Cancer Conference
Time of Update: 2022-04-18
As a result, the CameL-sq study has refreshed the current median overall survival record of the phase III randomized controlled trial (RCT) of immunotherapy combined with chemotherapy in the first-line treatment of advanced lung squamous cell carcinoma, and camrelizumab combined with chemotherapy has created a new survival data height (including median OS and 3-year OS rate) [3] , bringing a new breakthrough in the field .
-
[Free for a limited time] BioBAY in the trade medical park is here!
Time of Update: 2022-04-17
China's biopharmaceutical industry has maintained rapid and vigorous development for a long time, especially when the epidemic is raging, the urgency and importance of biopharmaceutical development ar
-
【Live Playback】Maintenance of Purified Water Equipment
Time of Update: 2022-04-16
[Pharmaceutical Network Technical Article] Good maintenance is the guarantee for the long-term stable operation of purified water equipment and prolonging the service life of the equipment .
-
[Live Playback] System Verification of Purified Water Equipment
Time of Update: 2022-04-15
[Pharmaceutical Network Technical Article] At 14:00 on February 24th, Jingderui will bring you a live broadcast on "Purified Water Equipment System Verification", which will be exciting to continue, so stay tuned!
